Pharmaceutical Biotechnology

Biography

Sandra Acosta has completed her BS Biology/Industrial Microbiology with Minor Degree in Music and Statistics with more than thirty (30+) years of extensive experience and expertise in validation principles, QA, GMP, Quality compliance, Engineering, regulatory in the Biotechnology/Pharmaceutical fields. She served fifteen years in the consulting business as a Scientist Consultant, Manager, and Director, within the Biotechnology/Pharmaceutical fields, Food, Spirits/beverage, Agriculture, Environmental, Medical, Cell-Therapy, OTC Cosmetic and Research Industries throughout her professional career. She participates as a workshop speaker within different disciplines of expertise within the Biotech/Pharmaceutical industries trends and most modern practices. She has ten years of experience in regulatory field between global marketing authorizations and plant documents/practices and more than ten years in Biotech/Pharma in addition of twenty years of experience in cGMP’s, and global regulations. She participates in business unit adjudication processes and action plan execution in conjunction with Quality Units, and closely interfaces with stakeholders/FDA, managing multicultural professional groups in US/EU.Sandra Acosta has completed her BS Biology/Industrial Microbiology with Minor Degree in Music and Statistics with more than thirty (30+) years of extensive experience and expertise in validation principles, QA, GMP, Quality compliance, Engineering, regulatory in the Biotechnology/Pharmaceutical fields. She served fifteen years in the consulting business as a Scientist Consultant, Manager, and Director, within the Biotechnology/Pharmaceutical fields, Food, Spirits/beverage, Agriculture, Environmental, Medical, Cell-Therapy, OTC Cosmetic and Research Industries throughout her professional career. She participates as a workshop speaker within different disciplines of expertise within the Biotech/Pharmaceutical industries trends and most modern practices. She has ten years of experience in regulatory field between global marketing authorizations and plant documents/practices and more than ten years in Biotech/Pharma in addition of twenty years of experience in cGMP’s, and global regulations. She participates in business unit adjudication processes and action plan execution in conjunction with Quality Units, and closely interfaces with stakeholders/FDA, managing multicultural professional groups in US/EU.

Abstract

Abstract : Multidrug-effl ux pumps inhibitors study on selected medicinal plants